Capital Change Notice - Issue of Options

07 September 2022
Capital Change Notice

This notice is given under NZX Listing Rule 3.13.1 and relates to the unlisted Options to acquire ordinary shares in the Company (‘Options’) issued under the Fisher & Paykel Healthcare 2022 Share Option Plan (the ‘Option Plan’), Fisher & Paykel Healthcare 2022 Performance Share Option Sub Plan (‘the Sub-Plan for France) and the Fisher & Paykel Healthcare (North American) 2022 Share Option Plan (the ‘North American Plan’).

Section 1: issuer information
Name of issuer Fisher & Paykel Healthcare Corporation Limited
NZX ticker code FPH
Class of Financial Product Options issued under the 2022 Option Plan, the 2022 Sub-Plan for France and the 2022 North American Plan
ISIN Not applicable
Section 2: capital change details
Number issued 896,130
Nominal value (if any) There is no nominal value for the Options.
Issue price No amount is payable for the grant of Options. The Options have an exercise price of $19.63 per share (being the volume weighted average price for a share on the NZX for the five business days prior to the grant date)
Nature of the payment Not applicable
Amount paid up (if not in full) Not applicable
Percentage of total class of Financial Products issued 896,130 Options to acquire ordinary shares representing approximately 0.15516% of the ordinary shares on issue
For an issue of Convertible Financial Products or Options, the principal terms of Conversion Not applicable
Reason for issue and specific authority for issue Issue of Options under the Option Plan, the Sub-Plan for France and the North American Plan to incentivise selected employees to grow the Company and to attract, motivate and retain key employees.
Total number of Financial Products of the Class after the issue (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue. 2,755,126 Options
In the case of an acquisition of shares, whether those shares are to be held as treasury stock Not applicable
Specific authority for the issue Directors’ resolution dated 24 August 2022
Terms or details of the issue The Options will be issued on the terms of the 2022 Option Plan, the 2022 Sub-Plan for France and the 2022 North American Plan in the form approved by the Board
Date of issue 07 September 2022
Section 3: authority for this announcement
Name of person authorised to make this announcement
Raelene Leonard
Contact phone number +64 9 574 0110
Contact email address [email protected]
Date of release via MAP 07 September 2022

---

Announcement PDF